Secondary Myocardial Ischemia Quiz

<p>Myocardial infarction (D)</p> Signup and view all the answers

<p>Acute coronary syndrome (C)</p> Signup and view all the answers

<p>0.5 mg once daily (A)</p> Signup and view all the answers

<p>With a light snack (D)</p> Signup and view all the answers

<p>1-2 weeks before the quit date (D)</p> Signup and view all the answers

<p>Lactating women (A)</p> Signup and view all the answers

<p>Nausea (D)</p> Signup and view all the answers

<p>1 mg twice daily (B)</p> Signup and view all the answers

<p>60mg orally then 180mg orally then 10mg a day (A)</p> Signup and view all the answers

<p>Decrease the dosage (C)</p> Signup and view all the answers

<p>Insomnia (C)</p> Signup and view all the answers

<p>Ticagrelor (B)</p> Signup and view all the answers

<p>Smokers with time-to-first cigarette (TTFC) of 30 minutes or less may receive a higher dose of clopidogrel. (C)</p> Signup and view all the answers

<p>21mg (D)</p> Signup and view all the answers

<p><a href="http://www.precisedaptscore.com/predapt/webcalculator.html">www.precisedaptscore.com/predapt/webcalculator.html</a> (A)</p> Signup and view all the answers

<p>To predict bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy. (D)</p> Signup and view all the answers

<p>Prasugrel (A), Ticagrelor (B)</p> Signup and view all the answers

<p>The Lancet (C)</p> Signup and view all the answers

<p>≥36 (C)</p> Signup and view all the answers

<p>0.88% (D)</p> Signup and view all the answers

<p>0.42% (B)</p> Signup and view all the answers

<p>Platelet count (B)</p> Signup and view all the answers

<p>0.88% (A)</p> Signup and view all the answers

<p>10 (C)</p> Signup and view all the answers

<p>3.85% (B)</p> Signup and view all the answers

<p>3.85% (B)</p> Signup and view all the answers

<p>11.0-11.5 (C)</p> Signup and view all the answers

<p>1.38% (A)</p> Signup and view all the answers

<blockquote> <p>5 (C)</p> </blockquote> Signup and view all the answers

<p>0.88% (D)</p> Signup and view all the answers

<p>60-70 years (D)</p> Signup and view all the answers

<p>3.85% (B)</p> Signup and view all the answers

<p>1.38% (C)</p> Signup and view all the answers

<p>5 (D)</p> Signup and view all the answers

<p>History of previous stroke (C)</p> Signup and view all the answers

<p>0 (A)</p> Signup and view all the answers

<p>6 (B)</p> Signup and view all the answers

<p>1 (C)</p> Signup and view all the answers

<p>8 (C)</p> Signup and view all the answers

<p>Risk factors (B)</p> Signup and view all the answers

<p>Assessing the risk of someone developing a heart attack (B)</p> Signup and view all the answers

<p>3 (C)</p> Signup and view all the answers

<p>History of coronary revascularization (D)</p> Signup and view all the answers

<p>Moderate Risk (A)</p> Signup and view all the answers

<p>8.3% (A)</p> Signup and view all the answers

<p>A history of a stroke (D)</p> Signup and view all the answers

<p>The Modified HEART score uses a different type of troponin. (D)</p> Signup and view all the answers

<p>High Risk (C)</p> Signup and view all the answers

<p>Age 65 years or older (A), Known CAD (coronary stenosis of ≥ 50%) (B), Use of aspirin in prior 7 days (C), At least 3 risk factors for CAD (D)</p> Signup and view all the answers

Damage to the heart muscle due to factors other than coronary artery blockage.

Bruising of the heart muscle, often occurring after trauma.

Substances that can damage the heart, such as certain chemotherapy drugs and carbon monoxide.

A condition where damaged skeletal muscle releases toxins that can affect the heart.

A condition characterized by temporary weakening of the heart muscle, often induced by stress.

A scoring system used to evaluate the likelihood of non-ST elevation myocardial infarction.

A history indicating a high likelihood of myocardial infarction, scored as 2.

A history suggesting a moderate likelihood of myocardial infarction, scored as 1.

A measure of electrical activity changes in the heart, where significant ST depression scores 2.

Age scoring in HEART Score where ≥ 65 years scores 2, indicating higher risk.

Factors such as diabetes, smoking, and hypertension considered for heart attack risk assessment.

Proteins released during heart injury; higher levels indicate greater risk, scoring up to 2.

When no significant risk factors are present, scoring 0 in the HEART Score.

A smoking cessation drug used to help quit smoking.

Days 1-3: 0.5 mg once daily; Days 4-7: 0.5 mg twice daily; Day 8-end: 1 mg twice daily.

Begin 1-2 weeks before the planned quitting date.

Condition where kidneys do not function adequately.

Should be used cautiously in those with renal insufficiency and lactating women.

Nausea, headache, insomnia, and abnormal dreams are common.

Methods like gum, patches, or lozenges to help quit smoking.

A chewing gum designed to help manage nicotine cravings when quitting smoking.

A tool predicting bleeding complications in patients on dual antiplatelet therapy post-stent implantation.

A thienopyridine antiplatelet used orally, frequently in cardiovascular conditions.

A thienopyridine antiplatelet agent taken orally, more potent than Clopidogrel.

An oral antiplatelet from the cyclopentyl-triazolopyrimidine class, known for reversible action.

No dose adjustments required for Clopidogrel, Prasugrel, and Ticagrelor in CKD stages 3 to 5.

Combined use of two antiplatelet agents to prevent thrombotic events after stenting.

A chemical class that Ticagrelor belongs to, known for its unique molecular structure.

A measure indicating smoking dependence; affects antiplatelet dosing outcomes in smokers.

A condition characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls.

A surgical procedure to restore blood flow to the heart muscle due to blocked arteries.

A scoring system used to assess the risk of adverse cardiac events in patients with UA/NSTEMI.

A TIMI score of 0-2 indicating a low risk of mortality or serious heart events.

A TIMI score of 5 or more indicating a high risk of mortality or serious heart events.

Episodes of chest pain due to reduced blood flow to the heart muscle.

Substances released into the blood when the heart is damaged, indicating potential heart problems.

High-sensitivity cardiac troponin is used in risk stratification to assess heart damage.

Non-ST Elevation Acute Coronary Syndrome, a type of heart condition.

A scoring system used to predict outcomes in acute coronary syndrome patients.

Bleeding that leads to significant clinical consequences, often requiring intervention.

Bleeding that is less severe, often self-limited and may not require major intervention.

A score used to assess bleeding risk in patients on dual antiplatelet therapy.

Concentration of hemoglobin in blood, vital for transporting oxygen.

Measure of the number of white blood cells in blood, often elevated in infections.

A test to measure kidney function by assessing creatinine levels.

History of bleeding events that affects current treatment risk assessment.

A numerical value assigned to assess risk of bleeding in patients.

Age is a significant predictor in cardiovascular risk assessments.

A finding on an ECG indicating significant heart injury or infarction.

A range of conditions resulting from reduced blood flow to the heart.

A type of study where outcomes are observed without intervention.